SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-005600
Filing Date
2023-08-11
Accepted
2023-08-11 17:21:41
Documents
54
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q coeptis_i10q-063023.htm   iXBRL 10-Q 1277229
2 CERTIFICATIONS coeptis_ex3101.htm EX-31.1 8261
3 CERTIFICATIONS coeptis_ex3102.htm EX-31.2 8184
4 CERTIFICATIONS coeptis_ex3201.htm EX-32.1 2534
5 CERTIFICATIONS coeptis_ex3202.htm EX-32.2 2523
  Complete submission text file 0001683168-23-005600.txt   7054114

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE coep-20230630.xsd EX-101.SCH 43695
7 XBRL CALCULATION FILE coep-20230630_cal.xml EX-101.CAL 47214
8 XBRL DEFINITION FILE coep-20230630_def.xml EX-101.DEF 191097
9 XBRL LABEL FILE coep-20230630_lab.xml EX-101.LAB 291279
10 XBRL PRESENTATION FILE coep-20230630_pre.xml EX-101.PRE 247989
48 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_i10q-063023_htm.xml XML 1450280
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39669 | Film No.: 231165254
SIC: 2836 Biological Products, (No Diagnostic Substances)